Page last updated: 2024-12-05
tetraethyltin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11704 |
| MeSH ID | M0102031 |
Synonyms (27)
| Synonym |
|---|
| nsc22315 |
| tetraethyltin |
| tetraethylstannane |
| stannane, tetraethyl- |
| 597-64-8 |
| wln: 2-sn-2&2&2 |
| nsc-22315 |
| tin, tetraethyl- |
| tetraethyl tin |
| brn 3600335 |
| hsdb 6398 |
| nsc 22315 |
| einecs 209-906-2 |
| inchi=1/4c2h5.sn/c4*1-2;/h4*1h2,2h3; |
| rwwnqeopuockgr-uhfffaoysa- |
| tetraethyltin, 97% |
| 31re6na75o , |
| unii-31re6na75o |
| tetraethyl tin [hsdb] |
| et4sn |
| snet4 |
| (c2h5)4sn |
| DTXSID9022073 |
| mfcd00009020 |
| tetraethylstannane; nsc 22315; tetraethyltin |
| tin tetraethyl |
| Q186600 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The battery of tests was administered on eight occasions, that is, before, at three-week intervals during dosing (PO or IP, five days each week for 15 weeks), and at three and six weeks after dosing." | ( Assessment of chemicals using a battery of neurobehavioral tests: a comparative study. Mitchell, CL; Pryor, GT; Tilson, HA; Uyeno, ET, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 25.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.05) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||